Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yves Mainguy"'
Autor:
Delphine Allain, Yves Mainguy, Martine Galissié, Martine Le Gal, Katell Le Lay, Axelle Nadjar
Publikováno v:
Joint Bone Spine. 77:165-170
Context The multidimensional nature of the fibromyalgia syndrome means that different instruments need to be used to assess the patients’ perception of this constellation of physical and psychological symptoms and their impact on their daily lives.
Autor:
Katell Le Lay, Yves Mainguy, Martine Le Gal, Axelle Nadjar, Martine Galissié, Delphine Allain
Publikováno v:
Revue du Rhumatisme. 77:194-200
Resume Objectifs La symptomatologie complexe de la fibromyalgie necessite l’utilisation de plusieurs instruments pour evaluer la perception par le patient de cette constellation de symptomes physiques et psychologiques et identifier leur impact sur
Autor:
Richard H. Gracely, Yves Mainguy, Karin B. Jensen, Thorsten Giesecke, Peter Fransson, Martin Ingvar, Frank Petzke, Eva Kosek, Serena Carville, Steven Williams, Ernest Choy, Hanke Marcus
Publikováno v:
Pain. 144:95-100
Over the years, many have viewed Fibromyalgia syndrome (FMS) as a so-called "functional disorder" and patients have experienced a concomitant lack of interest and legitimacy from the medical profession. The symptoms have not been explained by periphe
Autor:
Yves Mainguy
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 24:S19-S23
Functional imaging has been used to study response to pain in fibromyalgia patients. Functional magnetic resonance imagery (fMRI) which tracks local changes in blood flow has a higher spatial and temporal resolution than other techniques such as posi
Autor:
Karin B. Jensen, Frank Petzke, Yves Mainguy, Richard H. Gracely, Steven Williams, Serena Carville, Martin Ingvar, Hanke Marcus, Eva Kosek, Peter Fransson, Ernest Choy
Publikováno v:
Scandinavian journal of pain. 4(2)
Background In recent years, the prescription of serotonin-noradrenalin reuptake inhibitors (SNRIs) for treatment of fibromyalgia (FM) has increased with reports of their efficacy. The SNRI milnacipran is approved by the U.S. Food and Drug Administrat
Autor:
Jean Cabane, Yves Mainguy, Daniel Rivière, Anne Dumolard, Fabien Pillard, Laurence Negre-Pages, Robert Juvin, Michel Lanteri-Minet, Yves-Michel Maugars, Pierre Hatron, B. Auvinet, Denis Chaleil
Publikováno v:
BMC Musculoskeletal Disorders, Vol 12, Iss 1, p 258 (2011)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders
Background Fibromyalgia (FM) is a heterogeneous syndrome and its classification into subgroups calls for broad-based discussion. FM subgrouping, which aims to adapt treatment according to different subgroups, relies in part, on psychological and cogn
Autor:
Philip J, Mease, Daniel J, Clauw, Robin, Christensen, Leslie J, Crofford, R Michael, Gendreau, Susan A, Martin, Lee S, Simon, Vibeke, Strand, David A, Williams, Lesley M, Arnold, Yves, Mainguy
Publikováno v:
Journal of Rheumatology, 38(7), 1487-1495. Journal of Rheumatology Publishing Co. Ltd.
Following development of the core domain set for fibromyalgia (FM) in Outcome Measures in Rheumatology Clinical Trials (OMERACT) meetings 7 to 9, the FM working group has progressed toward the development of an FM responder index and a disease activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e28a55458ba6b57a1c10a74bbd0c1e
https://cris.maastrichtuniversity.nl/en/publications/55aba72c-279e-4085-8a23-37c1f5e91baf
https://cris.maastrichtuniversity.nl/en/publications/55aba72c-279e-4085-8a23-37c1f5e91baf
A Dose Dumping Study with a Sustained-Release Formulation of Bunazosin (E1015) in Healthy Volunteers
Autor:
Nobumichi Morishita, Norbert Bromet, Paul Branagan, Yoshiro Tomono, Maguy Bromet-Petit, Yves Mainguy
Publikováno v:
Drug Investigation. 6:1-4
The pharmacokinetics of a single oral dose of sustained-release bunazosin 6mg were compared under fasting and nonfasting conditions in 12 healthy volunteers. Following ingestion of a high fat (59g) meal, the extent of gastrointestinal absorption of b
Autor:
Eva Kosek, Serena Carville, Richard H. Gracely, Martin Ingvar, Steven Williams, Frank Petzke, Karin B. Jensen, Ernest Choy, Yves Mainguy, Hanke Marcus, Peter Fransson
Publikováno v:
Arthritis and rheumatism. 62(11)
Objective: Mood disturbance is common among patients with fibromyalgia (FM), but the influence of psychological symptoms on pain processing in this disorder is unknown. We undertook the present study to investigate the differential effect of depressi
Publikováno v:
The Journal of rheumatology. 37(4)
Objective.This randomized, double-blind, placebo-controlled, multicenter study investigated the efficacy and safety of milnacipran in the treatment of fibromyalgia (FM) in a European population.Methods.Outpatients diagnosed with FM according to 1990